Clinical Guides
Miscarriage
An India-contextualised, clinically focused guide to confirmed early miscarriage, safe choice of expectant, medical or surgical management, anti-D decisions and emergency escalation.
MedNext Academy | 12 min read
Miscarriage
An India-contextualised, clinically focused guide to confirmed early miscarriage, safe choice of expectant, medical or surgical management, anti-D decisions and emergency escalation.
Summary
Miscarriage is pregnancy loss before fetal viability; this guide addresses the early-pregnancy assessment and management pathway covered by current guidelines up to 13 completed weeks. Bleeding and pain alone do not diagnose a miscarriage. Pregnancy location and viability must be established appropriately, because ectopic pregnancy, pregnancy of unknown location and a potentially viable intrauterine pregnancy require different action. Use respectful language, acknowledge the loss and avoid implying that ordinary activity caused it.
After a confirmed miscarriage, expectant, medical and surgical management can be appropriate depending on clinical stability, infection, bleeding risk, gestation, access to follow-up and informed preference. Choice is meaningful only when the person has clear information on what will happen, likely bleeding and pain, analgesia, emergency contact, follow-up and the possibility of needing another intervention. Treatment is not a race: a stable person should not be pushed toward an intervention solely for service convenience.
Follow-up is part of treatment, not an administrative afterthought. The person needs a named route for unplanned deterioration, a plan for persistent symptoms and a pregnancy test at the recommended time after apparent completion. Clinicians should review whether the original diagnosis still fits before repeating medication or arranging an elective procedure. Consent includes the possibility that expectant or medical management may not complete the process and that surgery may later become appropriate. Continuity also protects against duplicate treatment when care moves between emergency, ultrasound, clinic and community services.
Severe bleeding, collapse, shock, fever, offensive discharge, marked pain or ectopic-pregnancy concern changes the pathway to urgent resuscitation and senior gynaecology assessment. The exact medicine regimen and anti-D indication must follow the current protocol and gestational age, not a remembered rule. [current guidelines, sections 1.9 to 1.12 and 1.18]
How Common Is It?
Early pregnancy bleeding and loss are common clinical presentations, but this guide does not state an Indian national miscarriage rate because prevalence depends on whether biochemical, ultrasound-confirmed and clinically recognised pregnancies are counted. Referral-hospital rates are affected by ultrasound availability, access to early-pregnancy units, gestational dating, self-management, stigma and reporting. A foreign estimate should not be converted into local epidemiology without a compatible population and definition.
The important service measure is safe timeliness. A unit should know how quickly a person with pain or bleeding can access pregnancy assessment, ultrasound, RhD status where relevant, analgesia, emergency blood products, uterine evacuation and follow-up. It should also audit unplanned reattendance, infection, transfusion, repeat treatment and positive follow-up pregnancy tests rather than assuming that a treatment is complete because medication was dispensed.
Clinical coding must preserve uncertainty. A person assessed for bleeding may later have a viable intrauterine pregnancy, an ectopic pregnancy, a pregnancy of unknown location or a confirmed miscarriage. Counting every attendance as a loss distorts both care planning and patient communication. Conversely, an apparent complete miscarriage still requires a route back to care if pain, bleeding, fever or a pregnancy test is concerning. Service planning should therefore measure diagnostic completion, access to ultrasound and documented safety-netting, not only the final procedure rate.
Repeated miscarriage has a different assessment pathway from a single early loss, and ectopic pregnancy must not be hidden in an aggregate miscarriage count. Age, previous pregnancy history and comorbidity modify risk but do not predict an individual outcome with certainty. Communication should be factual and compassionate; an epidemiological statement never explains a particular loss. [current guidelines overview and sections 1.2 and 1.10]
Risk Factors
Take a reproductive history that includes gestation, previous miscarriages, ectopic pregnancy, surgery, fertility treatment, menstrual dating, contraception, blood group if known and current symptoms. Maternal age, previous losses, uterine factors, endocrine disease, antiphospholipid syndrome, chromosome abnormalities, smoking and poorly controlled systemic disease may alter the probability of loss or influence further assessment, but they do not prove the cause of an individual event. Avoid exhaustive testing during an unstable presentation.
Risk of management harm is more immediately actionable. Late first-trimester bleeding, anaemia, coagulopathy, anticoagulants, inability to accept transfusion, infection, severe pain, unreliable access to emergency care and previous traumatic pregnancy experience can make simple expectant management unsuitable. Confirm allergies, medicines, previous uterine procedures and safeguarding needs. Never assume a person can return easily for review, has privacy for bleeding at home or can safely obtain prescribed medicines.
A pregnancy of uncertain location or a positive test with pain must retain ectopic pregnancy in the differential. Risk information does not replace ultrasound and serial biochemical assessment when these are clinically indicated. In India, access to RhD testing, emergency transfer and follow-up varies; build this into the management choice rather than labelling missed review as non-compliance. [current guidelines 1.10.1 and diagnosis sections]
Diagnosis
History
Document bleeding amount and progression, passage of tissue, pain site and severity, shoulder-tip pain, dizziness, syncope, fever, discharge, urinary or bowel symptoms and gestational dates. Ask about previous ultrasound, fertility treatment, ectopic pregnancy, surgery, RhD status, medicines and bleeding disorders. Determine whether the pregnancy was confirmed intrauterine and whether a heartbeat was documented. Respectfully ask what the person understands, whom they want involved and whether there are immediate safety, language or bereavement needs.
Examination
Assess observations, shock, pallor, abdominal tenderness, guarding and signs of sepsis first. A pelvic examination is performed only when it will answer a management question and with consent, privacy and a chaperone according to local policy. Cervical, vaginal or uterine findings cannot safely substitute for pregnancy-location assessment. Severe unilateral pain, peritonism, shoulder-tip pain, collapse or haemodynamic instability requires emergency ectopic-pregnancy consideration.
Investigations
Use transvaginal ultrasound where appropriate to establish viability and pregnancy location; apply validated criteria and repeat imaging when uncertainty remains rather than making an irreversible diagnosis from an equivocal scan. Serum hCG has a focused role in selected pathways and must be interpreted with symptoms and imaging. Obtain blood group/RhD status, haemoglobin, infection tests or cross-match when clinically indicated. Do not delay resuscitation for a complete diagnostic panel. [current guidelines diagnosis sections and 1.2]
Differential Diagnosis
Threatened miscarriage describes bleeding with a confirmed viable intrauterine pregnancy, not a miscarriage that has already been diagnosed. Current guidelines offers vaginal micronised progesterone 400 mg twice daily to a person with scan-confirmed intrauterine pregnancy, vaginal bleeding and a previous miscarriage; if a fetal heartbeat is confirmed, it recommends continuing until 16 completed weeks. This exact regimen applies to that defined threatened-miscarriage group and must not be transplanted to unconfirmed location, established miscarriage or a person with different contraindications.
Incomplete miscarriage, missed miscarriage and complete miscarriage have different findings and follow-up needs. Ectopic pregnancy, pregnancy of unknown location, cervical or vaginal lesions, molar pregnancy, urinary disease, appendicitis, ovarian torsion and non-gynaecological abdominal pathology can produce overlapping symptoms. A positive test does not locate a pregnancy, and tissue passed at home does not prove that ectopic pregnancy is excluded.
Sepsis, haemorrhage and retained tissue are complications rather than reassuring explanations for persisting symptoms. If pain, bleeding or fever worsens, reassess the diagnosis and location rather than simply repeating analgesia. [current guidelines 1.9.2 to 1.9.3 and diagnosis guidance]
Management
For a stable person with confirmed miscarriage, current guidelines uses expectant management for 7 to 14 days as first-line, while exploring other options when there is increased haemorrhage risk, infection, major consequence of haemorrhage or a prior adverse or traumatic pregnancy experience. Give oral and written information on expected bleeding and pain, analgesia, emergency access and alternatives. If symptoms settle, advise a urine pregnancy test three weeks after miscarriage and individualised review if it remains positive.
Offer medical management when expectant management is unacceptable or not appropriate. For missed miscarriage, current guidelines specifies 200 mg oral mifepristone followed 48 hours later by 800 micrograms misoprostol by vaginal, oral or sublingual route unless the gestational sac has already passed. If bleeding has not started within 48 hours after misoprostol, contact the treating service. For incomplete miscarriage, current guidelines specifies a single 600 microgram dose of misoprostol by vaginal, oral or sublingual route; 800 micrograms is an alternative to align protocols.
Offer pain relief and anti-emetics as needed with medical management. Surgical choice, where clinically appropriate, is manual vacuum aspiration under local anaesthetic in clinic or outpatient care, or theatre management under general anaesthetic. The source of medicines, consent, monitoring and discharge plan must be local and documented. [current guidelines 1.10 to 1.12]
Prescribing Information
Medical management must start only after confirmation of the diagnosis and a plan for bleeding, pain, contact and follow-up. The prescribed missed-miscarriage sequence is 200 mg oral mifepristone, then 48 hours later 800 micrograms misoprostol by vaginal, oral or sublingual route unless the sac has passed. In incomplete miscarriage, the current guidelines regimen is one 600 microgram misoprostol dose by those routes, with 800 micrograms permitted as an alternative for protocol alignment. Do not combine, repeat or substitute doses from memory.
Provide analgesia and anti-emetics as needed, but select agent, dose, route and maximum from the current local formulary after allergy, renal, gastrointestinal, bleeding and pregnancy assessment. Explain expected cramping and bleeding, the action if bleeding has not begun after the specified review interval, and emergency symptoms. Do not send a person home without a reachable service, written instructions and a feasible transport plan.
Anti-D advice has changed. Current guidelines states not to offer anti-D for ectopic pregnancy, miscarriage or threatened miscarriage up to and including 11+6 weeks. For RhD-negative people at 12+0 to 12+6 weeks undergoing medical management or a surgical procedure for miscarriage, it recommends at least 250 IU, equivalent to 50 micrograms. This is current UK guidance; verify the Indian blood-product protocol, product availability and gestation before prescribing. [current guidelines 1.11 and 1.18]
When to Refer
Urgent gynaecology or emergency referral is required for haemodynamic instability, collapse, ongoing heavy bleeding, severe or unilateral pain, shoulder-tip pain, peritonism, sepsis, suspected ectopic pregnancy, inability to exclude pregnancy location in a deteriorating person, or lack of safe follow-up. Resuscitate with local haemorrhage and sepsis pathways while arranging transfer; do not wait for a repeat scan when shock is present.
Early-pregnancy specialist review is appropriate for diagnostic uncertainty, persistent or increasing symptoms after expectant management, bleeding that has not started or is unresolved after medical management, a positive three-week pregnancy test, recurrent loss, suspected molar pregnancy, complex medical disease, anticoagulation or a person who wants procedural management. Referral is also appropriate when bereavement, safeguarding, language, privacy or travel factors make outpatient management unsafe.
In India, transfer early if ultrasound, blood products, RhD testing, uterine evacuation, anaesthesia, laboratory support or an after-hours contact route is unavailable. Include gestation and dating basis, ultrasound result, hCG where used, blood group, observations, bleeding estimate, medicines already given, allergies and infection concern. [current guidelines 1.10 to 1.12 and 1.18]
Red Flags
Heavy or continuously increasing bleeding, fainting, dizziness, pallor, tachycardia, hypotension, severe abdominal or shoulder-tip pain, guarding, collapse, fever, rigors, offensive discharge or feeling acutely unwell require urgent assessment. These features can indicate haemorrhage, sepsis, ectopic pregnancy or another surgical abdomen. A person should not be reassured by a previous scan if their clinical condition is changing.
After medical management, failure of bleeding to start within 48 hours after misoprostol is a defined reason to contact the treating professional for individualised care. Worsening or persistent bleeding and pain after expectant management require repeat scan and a new discussion of expectant, medical and surgical options. A positive pregnancy test three weeks after apparent completion also needs review; it may represent retained tissue, ongoing pregnancy or another diagnosis.
Use a lower threshold for emergency review when transport is difficult, the person is alone, anaemia or coagulopathy is present, transfusion is unacceptable or there is no reliable phone access. Record explicit return precautions in the preferred language and identify the receiving facility. [current guidelines 1.10.5 to 1.10.7 and 1.11.2]
Indian Clinical Context
This guide relies on current and RCOG sources because it does not identify a single India-wide document that provides the same detailed sequence for expectant, medical and surgical miscarriage management and the 2026 anti-D update. These sources are not Indian law, a local blood-bank standard or a substitute for Indian product labels. Local gynaecology, transfusion, antimicrobial, pain and emergency protocols govern practice.
Discuss access honestly: ultrasound, trained evacuation providers, mifepristone and misoprostol supply, analgesia, anti-D, blood products, telephone follow-up and transport may vary. A stable person can make a genuine choice only if each option is actually available with safety support. Community myths, self-blame, pressure from family and stigma deserve respectful attention but must not obscure urgent ectopic, haemorrhage or sepsis assessment.
NMC curricula support supervised learning; they do not authorise an undergraduate to diagnose miscarriage from a single scan, prescribe uterotonics, administer blood products or manage a complication alone. Where capacity is limited, stabilise, communicate and transfer rather than offering an incomplete home pathway. [NMC CBME Curriculum 2024; current guidelines]
NMC Competency Mapping
Early pregnancy loss integrates embryology, obstetric ultrasound, pharmacology, transfusion medicine, emergency care, consent, bereavement communication and reproductive rights. NMC CBME 2024 is the undergraduate framework, but no condition-specific code is invented here. Institutions should map this clinical encounter to their current approved ledger and expected supervision.
A learner should take a respectful bleeding-and-pain history, recognise shock and ectopic red flags, understand why location and viability must be confirmed, explain the difference between expectant, medical and surgical approaches, and document medicines, RhD status and follow-up. They should communicate uncertainty without false reassurance and give clear safety-net advice in the patient’s preferred language.
Under supervision, students may observe ultrasound counselling, support consent and bereavement care, check written discharge advice and make a structured referral handover. They must not independently diagnose non-viability, give mifepristone, misoprostol or anti-D, perform uterine evacuation or decide that bleeding is safe remotely. Assessment should test safety and communication as well as factual regimens. [NMC CBME Curriculum 2024, curriculum framework]
Key Exam Pearls for NEET PG
Bleeding in early pregnancy is not synonymous with miscarriage. First identify stability, pregnancy location and viability; ectopic pregnancy remains a dangerous differential. Expectant management is first-line for 7 to 14 days after confirmed miscarriage when appropriate, but infection, haemorrhage risk, major consequence of bleeding and traumatic history can make another option preferable.
For missed miscarriage, current guidelines: mifepristone 200 mg orally, then 48 hours later misoprostol 800 micrograms by vaginal, oral or sublingual route unless the sac has passed. For incomplete miscarriage, a single 600 microgram misoprostol dose by those routes is recommended, with 800 micrograms an accepted protocol-alignment alternative. Provide analgesia and anti-emetics as needed; prescribe only within a verified local pathway.
Current current guidelines anti-D distinction: do not offer it up to 11+6 weeks for miscarriage, threatened miscarriage or ectopic pregnancy; at 12+0 to 12+6 weeks, RhD-negative people undergoing medical or surgical management should receive at least 250 IU, 50 micrograms. [current guidelines sections 1.10, 1.11 and 1.18]
Frequently Asked Questions
Can bleeding in early pregnancy be called a miscarriage before ultrasound?
No. Bleeding and pain can occur with threatened miscarriage, ectopic pregnancy, pregnancy of unknown location and a viable intrauterine pregnancy. Urgency depends on symptoms and stability, while ultrasound and selected tests clarify location and viability. Severe pain, shoulder-tip pain, collapse, heavy bleeding, fever or feeling acutely unwell needs urgent assessment instead of waiting for a routine scan. Do not take a negative home symptom pattern as proof that a potentially life-threatening ectopic pregnancy has been excluded.
What are the verified current guidelines medicines for missed miscarriage?
For confirmed missed miscarriage, current guidelines recommends 200 mg oral mifepristone, then 48 hours later 800 micrograms misoprostol by vaginal, oral or sublingual route unless the gestational sac has already passed. This regimen is not a home prescription template: diagnosis, consent, analgesia, emergency access, follow-up and local medicine policy must be in place. Contact the service if bleeding has not started within 48 hours after misoprostol.
When is anti-D needed after early miscarriage?
current guidelines’s June 2026 update says not to offer anti-D for miscarriage, threatened miscarriage or ectopic pregnancy up to and including 11+6 weeks. At 12+0 to 12+6 weeks, RhD-negative people having medical management or surgery for miscarriage should receive at least 250 IU, equal to 50 micrograms. Indian transfusion protocols and product availability must be checked before an order is made.
When should surgical management be discussed or urgently arranged?
Surgical management is one of the informed choices after confirmed miscarriage and may be manual vacuum aspiration under local anaesthetic or theatre treatment under general anaesthetic when clinically appropriate. Heavy continuous bleeding, infection, haemodynamic instability or unsuccessful medical treatment can make urgent surgery necessary. In a stable case, the discussion should include alternatives, anaesthesia, complications, recovery and the person’s wishes rather than presenting surgery as the automatic option.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic